We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.61%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.6B
AUM Growth
+$1.7B
(+3.6%)
Cap. Flow
+$117M
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
16.96%
Holding
3,019
New
199
Increased
1,870
Reduced
823
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$61.6M |
| 2 |
Microsoft
MSFT
|
+$29.1M |
| 3 |
Evergy
EVRG
|
+$26.2M |
| 4 |
Amazon
AMZN
|
+$25.8M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$130M |
| 2 |
MON
Monsanto Co
MON
|
+$88.9M |
| 3 |
Apple
AAPL
|
+$21.2M |
| 4 |
Keurig Dr Pepper
KDP
|
+$18.4M |
| 5 |
Gilead Sciences
GILD
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.45% |
| 2 | Financials | 16.24% |
| 3 | Healthcare | 13.05% |
| 4 | Consumer Discretionary | 10.25% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
2076
DELISTED
Revance Therapeutics, Inc.
RVNC
| $863K | ﹤0.01% |
31,453
+7,287
| +30% | +$219K |
|
2077
Acushnet Holdings
GOLF
$5.98B
| $862K | ﹤0.01% |
35,225
+2,665
| +8% | +$64K |
|
2078
Motorcar Parts of America
MPAA
$257M
| $861K | ﹤0.01% |
46,039
+1,456
| +3% | +$30.4K |
|
|
FLXN
2079
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $859K | ﹤0.01% |
33,228
-184
| -0.6% | -$4.78K |
|
2080
Community Trust Bancorp
CTBI
$1.43B
| $857K | ﹤0.01% |
17,149
-24
| -0.1% | -$1.19K |
|
|
AHT
2081
Ashford Hospitality Trust
AHT
$21M
| $852K | ﹤0.01% |
106
+10
| +10% | +$69.8K |
|
2082
MBIA
MBI
$266M
| $851K | ﹤0.01% |
94,094
-3,485
| -4% | -$31.4K |
|
2083
Simply Good Foods
SMPL
$1B
| $851K | ﹤0.01% |
+58,957
| New | +$791K |
|
|
GMS
2084
DELISTED
GMS Inc
GMS
| $848K | ﹤0.01% |
31,308
+1,682
| +6% | +$51.1K |
|
|
GTHX
2085
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $848K | ﹤0.01% |
19,502
+7,772
| +66% | +$333K |
|
2086
CytomX Therapeutics
CTMX
$690M
| $847K | ﹤0.01% |
37,052
+8,100
| +28% | +$207K |
|
|
RCM
2087
DELISTED
R1 RCM Inc. Common Stock
RCM
| $846K | ﹤0.01% |
97,414
+5,770
| +6% | +$46.7K |
|
|
CNR
2088
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $846K | ﹤0.01% |
40,307
+3,245
| +9% | +$62.1K |
|
2089
Univest Financial
UVSP
$1.23B
| $842K | ﹤0.01% |
30,627
+1,524
| +5% | +$43.7K |
|
2090
TriCo Bancshares
TCBK
$1.85B
| $841K | ﹤0.01% |
22,455
+2,025
| +10% | +$77.5K |
|
|
MTGE
2091
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $841K | ﹤0.01% |
42,921
-2,820
| -6% | -$53.9K |
|
|
VCRA
2092
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $838K | ﹤0.01% |
28,046
+1,502
| +6% | +$39.9K |
|
|
NWLI
2093
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $837K | ﹤0.01% |
2,725
+110
| +4% | +$34.3K |
|
|
NRE
2094
DELISTED
NorthStar Realty Europe Corp.
NRE
| $836K | ﹤0.01% |
57,712
-5,826
| -9% | -$81.9K |
|
2095
Cerus
CERS
$433M
| $833K | ﹤0.01% |
124,813
+17,416
| +16% | +$107K |
|
2096
RPC Inc
RES
$1.28B
| $832K | ﹤0.01% |
57,099
-16,437
| -22% | -$281K |
|
|
HMHC
2097
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $829K | ﹤0.01% |
108,417
+7,426
| +7% | +$52.7K |
|
2098
Preferred Bank
PFBC
$1.26B
| $827K | ﹤0.01% |
13,461
+1,200
| +10% | +$77.5K |
|
|
MRTX
2099
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $827K | ﹤0.01% |
+16,770
| New | +$633K |
|
2100
Hawkins
HWKN
$2.76B
| $825K | ﹤0.01% |
46,648
+1,498
| +3% | +$25.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2018 Portfolio in Review
As of Q2 2018, RhumbLine Advisers held 3,019 positions worth $49.6B, up 3.6% from $47.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
RhumbLine Advisers's Q2 2018 filing shows 199 new, 1,870 increased, 823 reduced and 112 closed positions. Its largest new stake was Evergy: 490,078 shares worth $27.5M. The largest sale was Time Warner Inc, an estimated $130M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2018 buy was Evergy: 490,078 shares worth $27.5M.
- RhumbLine Advisers added most to AT&T in Q2 2018, an estimated $61.6M increase.
- RhumbLine Advisers's biggest Q2 2018 reduction was Apple, cutting an estimated $21.2M.
- RhumbLine Advisers fully exited Time Warner Inc in Q2 2018, selling an estimated $130M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $49.6B portfolio in Q2 2018.
- RhumbLine Advisers opened 199 new positions and closed 112 in Q2 2018.
- RhumbLine Advisers's portfolio value rose 3.6% quarter-over-quarter to $49.6B.
Based on RhumbLine Advisers's 13F filing for Q2 2018, filed 6 Aug 2018.